Selected research
Industry Research
Avanafil Tablets Industry Research Report 2026
Market perspective
The global Avanafil Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Avanafil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Avanafil Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Avanafil Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Avanafil Tablets include VIVUS, Sanofi, Huilun Pharmaceutical, Haisco Pharmaceutical, Menarini Group, JW Pharmaceutical, Endo International and Auxilium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Avanafil Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Avanafil Tablets Market by Company
VIVUS
Sanofi
Huilun Pharmaceutical
Haisco Pharmaceutical
Menarini Group
JW Pharmaceutical
Endo International
Auxilium Pharmaceuticals
Avanafil Tablets Segment by Type
50 mg
100 mg
200 mg
Avanafil Tablets Segment by Application
18-45 Years Old
46-60 Years Old
Other
Avanafil Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avanafil Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Avanafil Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avanafil Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Avanafil Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Avanafil Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Avanafil Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50 mg
- 100 mg
- 200 mg
Applications
- 18-45 Years Old
- 46-60 Years Old
- Other
Companies covered
- VIVUS
- Sanofi
- Huilun Pharmaceutical
- Haisco Pharmaceutical
- Menarini Group
- JW Pharmaceutical
- Endo International
- Auxilium Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Avanafil Tablets Market Size (2021-2032)
- 2.2.2 Global Avanafil Tablets Sales (2021-2032)
- 2.2.3 Global Avanafil Tablets Market Average Price (2021-2032)
- 2.3 Avanafil Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50 mg
- 2.3.3 100 mg
- 2.3.4 200 mg
- 2.4 Avanafil Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 18-45 Years Old
- 2.4.3 46-60 Years Old
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Avanafil Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Avanafil Tablets Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Avanafil Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Avanafil Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Avanafil Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Avanafil Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Avanafil Tablets, Product Type & Application
- 3.8 Global Manufacturers of Avanafil Tablets, Established Date
- 3.9 Global Avanafil Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 VIVUS
- 4.1.1 VIVUS Company Information
- 4.1.2 VIVUS Business Overview
- 4.1.3 VIVUS Avanafil Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 VIVUS Avanafil Tablets Product Portfolio
- 4.1.5 VIVUS Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Avanafil Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Avanafil Tablets Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Huilun Pharmaceutical
- 4.3.1 Huilun Pharmaceutical Company Information
- 4.3.2 Huilun Pharmaceutical Business Overview
- 4.3.3 Huilun Pharmaceutical Avanafil Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Huilun Pharmaceutical Avanafil Tablets Product Portfolio
- 4.3.5 Huilun Pharmaceutical Recent Developments
- 4.4 Haisco Pharmaceutical
- 4.4.1 Haisco Pharmaceutical Company Information
- 4.4.2 Haisco Pharmaceutical Business Overview
- 4.4.3 Haisco Pharmaceutical Avanafil Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Haisco Pharmaceutical Avanafil Tablets Product Portfolio
- 4.4.5 Haisco Pharmaceutical Recent Developments
- 4.5 Menarini Group
- 4.5.1 Menarini Group Company Information
- 4.5.2 Menarini Group Business Overview
- 4.5.3 Menarini Group Avanafil Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Menarini Group Avanafil Tablets Product Portfolio
- 4.5.5 Menarini Group Recent Developments
- 4.6 JW Pharmaceutical
- 4.6.1 JW Pharmaceutical Company Information
- 4.6.2 JW Pharmaceutical Business Overview
- 4.6.3 JW Pharmaceutical Avanafil Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 JW Pharmaceutical Avanafil Tablets Product Portfolio
- 4.6.5 JW Pharmaceutical Recent Developments
- 4.7 Endo International
- 4.7.1 Endo International Company Information
- 4.7.2 Endo International Business Overview
- 4.7.3 Endo International Avanafil Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Endo International Avanafil Tablets Product Portfolio
- 4.7.5 Endo International Recent Developments
- 4.8 Auxilium Pharmaceuticals
- 4.8.1 Auxilium Pharmaceuticals Company Information
- 4.8.2 Auxilium Pharmaceuticals Business Overview
- 4.8.3 Auxilium Pharmaceuticals Avanafil Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Auxilium Pharmaceuticals Avanafil Tablets Product Portfolio
- 4.8.5 Auxilium Pharmaceuticals Recent Developments
5 Global Avanafil Tablets Market Scenario by Region
- 5.1 Global Avanafil Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Avanafil Tablets Sales by Region: 2021-2032
- 5.2.1 Global Avanafil Tablets Sales by Region: 2021-2026
- 5.2.2 Global Avanafil Tablets Sales by Region: 2027-2032
- 5.3 Global Avanafil Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Avanafil Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Avanafil Tablets Revenue by Region: 2027-2032
- 5.4 North America Avanafil Tablets Market Facts & Figures by Country
- 5.4.1 North America Avanafil Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Avanafil Tablets Sales by Country (2021-2032)
- 5.4.3 North America Avanafil Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Avanafil Tablets Market Facts & Figures by Country
- 5.5.1 Europe Avanafil Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Avanafil Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Avanafil Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Avanafil Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Avanafil Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Avanafil Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Avanafil Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Avanafil Tablets Market Facts & Figures by Country
- 5.7.1 South America Avanafil Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Avanafil Tablets Sales by Country (2021-2032)
- 5.7.3 South America Avanafil Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Avanafil Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Avanafil Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Avanafil Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Avanafil Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Avanafil Tablets Sales by Type (2021-2032)
- 6.1.1 Global Avanafil Tablets Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Avanafil Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Avanafil Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Avanafil Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Avanafil Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Avanafil Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Avanafil Tablets Sales by Application (2021-2032)
- 7.1.1 Global Avanafil Tablets Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Avanafil Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Avanafil Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Avanafil Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Avanafil Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Avanafil Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Avanafil Tablets Value Chain Analysis
- 8.1.1 Avanafil Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Avanafil Tablets Production Mode & Process
- 8.2 Avanafil Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Avanafil Tablets Distributors
- 8.2.3 Avanafil Tablets Customers
9 Global Avanafil Tablets Analyzing Market Dynamics
- 9.1 Avanafil Tablets Industry Trends
- 9.2 Avanafil Tablets Industry Drivers
- 9.3 Avanafil Tablets Industry Opportunities and Challenges
- 9.4 Avanafil Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst